JulieJisunPaikMDMHS

Rheumatology • Baltimore, MD

Myositis, Scleroderma & Related

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Paik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Paik's full profile

Already have an account?

Office
5501 Hopkins Bayview Circle
Baltimore, MD 21224
Phone+1 443-997-1552

Fax+1 410-550-1033

Summary

Dr. Julie Paik is a rheumatologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 11 years. She also speaks multiple languages, including Korean. She specializes in myositis and scleroderma & related.

Education & Training

Johns Hopkins UniversityFellowship, Rheumatology, 2010 - 2013
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2006 - 2009
George Washington University School of Medicine and Health SciencesClass of 2006

Certifications & Licensure

CA State Medical License 2007 - Present
FL State Medical License 2020 - Present
MD State Medical License 2013 - 2025
NH State Medical License 2024 - 2024
VA State Medical License 2023 - 2024
NC State Medical License 2020 - 2022
OK State Medical License 2020 - 2021
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Study of Tofacitinib in Refractory Dermatomyositis Start of enrollment: 2017 Jan 01
Completed
Phase 1

Publications & Presentations

PubMed

65 citations
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Marcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, Jason C Collins, Hugh Alessi
Blood. 2022-09-29
92 citations
Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle
Iago Pinal-Fernandez, Cassie A. Parks, Jessie L. Werner, Jemima Albayda, Julie J. Paik
Arthritis Care & Research. 2017-02-01
112 citations
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Eleni Tiniakou, Iago Pinal-Fernandez, Thomas E. Lloyd, Jemima Albayda, Julie Paik
Rheumatology. 2017-05-01

Press Mentions

Most RMD Patients Retain Antibodies 6 Months After COVID-19 VaccinationFebruary 14th, 2022
COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
Researchers Describe First Reports of Breakthrough COVID Infections, Booster Shots in Rheumatology PatientsSeptember 13th, 2021
Join now to see all

Other Languages

Korean

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/julie-paik